Browse treatments

…sociated cognitive impairment is common in patients who receive chimeric antigen receptor T-cell (CAR-T) therapy. Hence, monitoring cognitive function is vital to guide treatme…

… treatment with high dose steroids, intravenous immunoglobulin, plasma exchange and rituximab he has had a significant clinical improvement. Ho…

…95g/L, and diagnosis of Guillain-Barre Syndrome was considered. Plasma exchange was commenced with no improvement in symptoms. Diffusion weight…

…itution inflammatory syndrome (IRIS). He completed 18 months of anti-mycobacterial therapy and corticosteroid therapy 6 months earlier.Examination reveale…

…uropathy presumed secondary to DLBCL.DLBCL treatment: Initiated R-CHOP chemotherapy, resulting in moderate neurological improvement.Autonomic dysfu…

…sed their prescribed doses on their own and 39.3% used whatever medications were available without prescriptions, which was significantly a…

…of AE patients with immunotherapy and in most FEP patients with antipsychotic treatment. Hospital length of stay was significantly longer in the AE coh…

…herapy-induced peripheral neuropathy (CIPN) can result in early chemotherapy cessation and chronic, disabling neuropathic symptoms. Duloxeti…

…. 95% of patients were treated, 84% with high efficacy therapy (HET). 87% exhibited NEDA(193/222) over a median of 31 months. NEDA …

…10 eyes of 269 patients affected by corneal blindness underwent MOOKP and were followed up for 15.9±12.0 years (up to 45 years). Anat…

…r Control TNM Classification of Malignant Tumours), followed by adjuvant chemotherapy, postmastectomy radiotherapy and ongoing adjuvant endocrine the…

…e parents perceived the football activities as complementary to physical therapy, supporting physical rehabilitation. Participation also enabled…